Inappropriately regulated inflammation of the gastrointestinal tract is common and debilitating, but poorly understood. This proposal focuses on neurogenic mechanisms of intestinal inflammation that induce plasma extravasation and leukocyte infiltration from post- capillary venules. Hypothesis: (1) Intestinal inflammation in initiated by release of the peptide substance P from sensory nerves and generation of bradykinin in plasma and tissues, and their interaction with specific receptors on endothelial cells. (2) Inflammation is terminated by cell-surface proteases that degrade substance P and bradykinin and by desensitization and down-regulation of receptors. (3) Pharmacological blockade or genetic deletion of these receptors or these proteases results in inappropriately initiated or terminated intestinal inflammation. These hypothesis will be tested in mice, due to preliminary results, and the availability of genetic models where receptors and enzymes have been deleted. Inflammation will be assessed by (1) quantifying and localizing extravasation of plasma proteins using Evans blue and Monastral blue, respectively; (2) assessing gap formation between endothelial cells by microscopy: (3) quantifying and localizing neutrophil infiltration using myeloperoxidase.
Specific Aim 1 will examine the involvement of substance P and bradykinin in initiation of inflammation. The time course and duration of effects of exogenous and endogenous peptides will be determined. The receptors mediating these effects will be identified using specific antagonists and genetic deletion, and localized using antibodies.
Specific Aim 2 will examine the role of cell-surface proteases and receptor desensitization in terminating inflammation. The role of neutral endopeptidase and angiotensin converting enzyme in terminating inflammation will be determined using specific inhibitors and genetic deletion. Desensitization of receptors will be examined by delineating the pathway of receptor endocytosis and recycling in endothelial cells.
Specific Aim 3 will evaluate if defects in initiation and termination mechanisms result in an inappropriate inflammatory response in well defined models of intestinal inflammation that have a known neurogenic component. Inflammation will be evaluated in mice in which the key receptors or cell-surface proteases are genetically deleted or are pharmacologically inhibited. These experiments will determine the mechanisms of initiation and termination of intestinal inflammation, evaluate if abnormalities in these mechanisms lead to an inappropriately regulated response, and provide new insights into the mechanisms and possible treatment for intestinal inflammation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052388-02
Application #
2713451
Study Section
Surgery and Bioengineering Study Section (SB)
Program Officer
Hamilton, Frank A
Project Start
1997-06-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Surgery
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Vergnolle, N; Cenac, N; Altier, C et al. (2010) A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation. Br J Pharmacol 159:1161-73
Lennerz, Jochen K; Ruhle, Victor; Ceppa, Eugene P et al. (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277-99
Cottrell, Graeme S; Amadesi, Silvia; Pikios, Stella et al. (2007) Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology 132:2422-37
Gazzieri, David; Trevisani, Marcello; Springer, Jochen et al. (2007) Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radic Biol Med 43:581-9
Cottrell, Graeme S; Padilla, Benjamin; Pikios, Stella et al. (2007) Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1. J Biol Chem 282:12260-71
Lessard, A; Grady, E F; Bunnett, N W et al. (2007) Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area. Neuroscience 144:1393-408
Clifton, Matthew S; Hoy, Julia J; Chang, Jen et al. (2007) Role of calcitonin receptor-like receptor in colonic motility and inflammation. Am J Physiol Gastrointest Liver Physiol 293:G36-44
Wick, Elizabeth C; Pikios, Stella; Grady, Eileen F et al. (2006) Calcitonin gene-related peptide partially mediates nociception in acute experimental pancreatitis. Surgery 139:197-201
Wick, Elizabeth C; Hoge, Steven G; Grahn, Sarah W et al. (2006) Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 290:G959-69
Cottrell, Graeme S; Padilla, Benjamin; Pikios, Stella et al. (2006) Ubiquitin-dependent down-regulation of the neurokinin-1 receptor. J Biol Chem 281:27773-83

Showing the most recent 10 out of 31 publications